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Abstract: The endoplasmic reticulum (ER) is an organelle that is responsible for many essential
subcellular processes. Interconnected narrow tubules at the periphery and thicker sheet-like regions
in the perinuclear region are linked to the nuclear envelope. It is becoming apparent that the complex
morphology and dynamics of the ER are linked to its function. Mutations in the proteins involved in
regulating ER structure and movement are implicated in many diseases including neurodegenerative
diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS). The ER is also
hijacked by pathogens to promote their replication. Bacteria such as Legionella pneumophila and
Chlamydia trachomatis, as well as the Zika virus, bind to ER morphology and dynamics-regulating
proteins to exploit the functions of the ER to their advantage. This review covers our understanding of
ER morphology, including the functional subdomains and membrane contact sites that the organelle
forms. We also focus on ER dynamics and the current efforts to quantify ER motion and discuss the
diseases related to ER morphology and dynamics.
Keywords: endoplasmic reticulum (ER); morphology; dynamics; anomalous diffusion; membrane
contact site (MCS); dynein; kinesin; microtubule
1. Introduction
The endoplasmic reticulum (ER) is a subcellular organelle responsible for a variety
of essential cellular functions. In the ER, proteins are synthesised and undergo post-
translational modification, calcium ions are stored and released as dictated by cellular
signaling, and lipids are biosynthesised. The ER is the largest organelle in the cell and
extends as a continuous membrane-bound entity from the nuclear envelope to the cell
periphery in a complex network of tubules and sheet-like regions. Fast dynamics and
re-organisation, along with the fact that the ER comprises ~35% of the cytoplasmic volume,
mean that the ER explores the volume of the cytoplasm more rapidly than any other
organelle [1]. Little is understood as of yet about the function of ER dynamics or the effects
of dynamics in ER-related diseases.
The complex structure of the ER is maintained by a variety of proteins including
reticulons, REEPs, and atlastins [2–4]. These morphology-regulating proteins promote
membrane curvature [2,3], drive tubule fusion [4–8], stabilise junctions [9–11], regulate
sheet spacing [12–14], and tether the ER to microtubules [15–17]. Cooperation between
these proteins is essential for normal morphology, with overexpression of certain types lead-
ing to abnormal proportions of sheets and tubules in the network [6,9,18]. The microtubule
motor proteins kinesin-1 and cytoplasmic dynein (referred to herein as dynein) also bind to
the endoplasmic reticulum to drive the formation of new tubules and to continuously and
dynamically remodel the network (e.g., [19,20]). Interactions between the ER and other or-
ganelles at membrane contact sites (MCSs) also contribute to the dynamics of the organelle
(Section 3.1.2). ER dynamics is an emerging topic of research. Historically, tubule extension
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speeds have been measured [20–23], but the quantification of other aspects of ER dynamics
has been challenging due to limitations in microscopy and computation. Recently, software
designed to analyse the motion of the ER in live cells has been published [24–27] and
further developments in this area are likely in the near future.
Although the relationship between ER dynamics and function is not yet understood,
abnormal ER dynamics have recently been linked to several diseases [8,28,29], indicating
that dynamics are likely to be very important. In contrast, disease-related mutations in
morphology-regulating proteins are rather better understood and links between morphol-
ogy and function have been established [30,31].
This review will detail the current understanding of ER morphology, dynamics, and
function and the interplay between them, as well as the diseases linked to abnormalities in
morphology and dynamics, focussing primarily on the ER in vertebrate cells. Section 2 will
describe ER morphology, the proteins involved in maintaining normal ER structure, and the
links between morphology and function that have been elucidated. Section 3 will describe
the dynamics of the ER, factors causing organelle motion, current efforts to quantify the
dynamics, and recent developments in computational analysis and modelling. Finally,
Section 4 will detail the known links between ER structure/motion and diseases as well as
the proteins involved in these diseases. A discussion of the subdomain organisation of the
ER specifically in neuronal cells is presented in another article of this special issue [32].
2. Morphology
A lipid bilayer bounds the lumen of the ER. This bilayer is formed into sheets and
tubules of roughly 80–100 nm diameter [25,33,34], with a range of ~50–100 nm [33], which
are connected at junctions to form a reticular network. Tubules are around 1 µm in length
on average and connect at junctions, usually joining 3 tubules [27,35]. The sheets are flat,
with a bilayer separation of 30–50 nm [33], and often occur in a stacked configuration
with helical ramps connecting the layers [36]. Sheet density is usually higher nearer the
centre of the cell (e.g., [33,37,38]), where the endoplasmic reticulum also includes the
nuclear envelope; however, sheet-like regions also occur in peripheral ER. Super-resolution
light microscopy has revealed that some peripheral structures originally thought to be
sheets actually consist of dense matrices of tubules [33,34,38], while others comprise sheets
fenestrated with tiny holes (nanoholes: [33]). Research into the proteins involved in shaping
the ER membrane is extensive and has been reviewed recently [30,31,39]. The complex
morphology of the ER has recently been linked to its function (reviewed in [40]) and can be
changed in response to altered metabolic requirements or cell cycle stage, as described later.
2.1. Morphology-Regulating Proteins
A plethora of proteins are involved in regulating ER morphology. These proteins
stabilise high membrane curvature regions, promote membrane fusion, maintain three-
way junctions, regulate sheet thickness and flatness, and anchor the ER to microtubules
(Figure 1).
ER tubules and sheet edges are regions of high membrane curvature. The hairpin-like
REEP and reticulon protein families promote curvature in the surface of the ER to stabilise
tubules and sheet edges [2,3]. Reticulon 4 also accumulates at the edges of nanoholes,
which are absent in Rtn4 knockout cells [33]. These proteins are thought to sit with the
wider end of the ‘hairpin’ at the outer edge of the membrane to promote curvature via
hydrophobic wedging, as shown in Figure 1C.
Membrane fusion is also essential to maintain correct ER morphology. Atlastin, an
ER-resident GTPase, is required for ER network maintenance and membrane fusion [4–6].
New tubules that are drawn out from the existing membranous structure must be fused
to the network to preserve normal ER morphology. Bian et al. proposed that atlastin is
resident in the membrane of both of the uniting edges and that a dimer is formed between
the two proteins [41] (see Figure 1F). This dimerisation would cause a conformational
change in which the proteins, and therefore the ER membrane, would be pulled closer
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together, eventually causing membrane fusion. Two RabGTPases, Rab10 [7], and Rab18 [8]
have also been implicated in ER tubule fusion. Depletion of either of these proteins
caused an increase in sheets and a decrease in tubules. Rab10 also localises to the growing
tips of ER tubules that are enriched in two lipid synthesis enzymes: phosphoinositol
synthase (PIS) and CEPT1 [7]. Interestingly, dynamin-related protein 1 (Drp1), a protein
required for mitochondrial fission, has been shown to lead to promote ER tubule formation
independently of Rtn4 [42].
Figure 1. Diagram showing the possible mechanisms of action of ER morphology-regulating proteins. (A) CLIMP-63, a
transmembrane ER protein, may regulate sheet thickness by forming a dimer, linking the two bilayers of an ER sheet.
(B) Lunapark locates to and stabilises three-way junctions in the ER network, although how this is achieved is not yet
known. (C) Proteins promoting membrane curvature, such as the reticulon and REEP families, are shaped like hairpins and
localise to tubules and sheet edges (regions of high membrane curvature). The proteins are embedded in the outer leaflet of
the bilayer, with the wider end at the surface, inducing membrane curvature. (D) Static interactions between the ER and
microtubules may be facilitated by CLIMP-63, p180, REEP1, and Sec61β. These proteins are all resident in the ER membrane
and possess microtubule-binding domains. (E) Tip attachment complexes (TACs) are formed by interactions between the
ER-resident protein STIM1 (pink) and the microtubule plus-end tracking protein EB1 (orange). (F) New tubules are fused
to the network by atlastin, an ER-resident GTPase, which may reside in both of the sections of ER membrane to be fused.
A dimer may be formed between the two proteins, promoting tubule fusion. Rab10, Rab18, and Drp1 may also promote
tubule fusion, although the mechanisms are currently unknown. (G) Polyribosomes, groups of ribosomes gathered on the
surfaces of ER sheet membranes, may maintain sheet flatness, although this has yet to be experimentally demonstrated.
The three-way junctions of the ER network in mammalian cells are stabilised by
mammalian Lnp1, a member of the Lunapark family [9–11]. mLnp1 localises to three-
way junctions in Cos-7 cells, and junctions lacking in mLnp1 were much more dynamic
and shorter-lived than their mLnp1-enriched counterparts [10]. Lunapark-free junctions
frequently disappeared by ring closure, in which junctions slide along a neighbouring
tubule until they coalesce with another junction, whereas ring closure was less common for
mLnp1 junctions [10]. Therefore, Lunapark stabilises three-way junctions in the network.
The cooperation of these proteins is crucial in ER morphology regulation. In order to
maintain normal ER morphology, a balance between reticulon 4a and atlastin expression
was required [6]. Long, unbranched tubules were seen in cells with little atlastin function
and in cells overexpressing reticulon 4a. Both atlastin and reticulon 4a expression in
Lunapark knockout cells restored normal network morphology at the cell periphery. In
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yeast, a balance between the Lunapark Lnp1p and the atlastin homologue Sey1p is required
for typical polygonal network formation [9]. Lunapark and atlastin also coordinate to form
and maintain three-way junctions in mammalian cells, with Lunapark unable to localise to
junctions when atlastins are deleted [18]. Using a different but complementary approach,
Shemesh et al. modelled the ER network, focusing on two classes of morphology regulating
proteins [43], with Lunapark being proposed to be a negative-curvature-inducing protein
and reticulons enhancing straight edges. Altering the expression level of Lunapark in
Cos-7 cells gave rise to different ER morphologies, and various network properties such
as the total length and the preferred shape of junctions were replicated by changing
protein concentrations in the simulations. Clearly, the relative concentrations of the ER
morphology-regulating proteins are of great importance for normal ER structure.
CLIMP-63, an integral membrane protein, has been suggested as a mechanism of
controlling the lumenal separation between the two membranes of ER sheets [12–14]. As
shown in Figure 1A, its large coiled coil domain sits within the lumen of the ER and
has been hypothesised to bind to the coiled coil domains of other CLIMP-63 proteins
to regulate sheet thickness [12]. Over-expression of CLIMP-63 induces the formation
of sheets containing nanoholes [33]. The second factor influencing sheet thickness may
be groups of ribosomes, also called polyribosomes, bound to the cytosolic face of the
ER [44] (see Figure 1G). Removing ribosomes from the ER surface converted sheets to
tubules, supporting the hypothesis that polyribosomes stabilise ER sheets [45]. p180 and
kinectin, two proteins that are similar in conformation to CLIMP-63, may play a role in
flattening the surface of sheets [13], although there is little conclusive evidence supporting
this idea. Both proteins are potential receptors for the microtubule motor kinesin-1 (see
Section 3.1.1). Microtubules and the actin cytoskeleton play a major role in regulating ER
position and morphology, both via dynamic and static links (Figure 1D,E), as discussed in
Section 3. Together, the proteins involved in cytoskeletal binding and motility, membrane
curvature stabilisation, tubule fusion, junction maintenance, and sheet thickness regulation
are essential for the maintenance of normal ER structure.
2.2. Structural and Functional ER Subdomains
Different structural domains of the ER, which are responsible for specific functions,
have been hypothesised since the first electron microscopy images of the ER were obtained.
In the 1950s, it was noticed by George E. Palade that ER sheets tended to be studded
with ribosomes, known as rough ER, whereas tubules were largely ribosome-free, or
smooth [46,47]. This difference in structure in different regions of the network sparked the
hypothesis of ER functional subdomains. Since then, significant work has been undertaken
to correlate the morphology of the ER with its function.
2.2.1. Protein Factory and Quality Control
The best-understood role of the ER is to synthesise and insert proteins into the ER
membrane or lumen, and this happens primarily by ribosomes associating with the cy-
tosolic face of the ER, where the newly synthesised polypeptide chain is translocated
through the Sec61 translocon, as reviewed in this special issue by Sicking et al. [48]. In
S. Cerevisiae, sheet ribosome density was found to be significantly larger than tubule ri-
bosome density [49]. As ribosomes attach to the ER to allow the translation of secreted
or membrane-bound proteins, this result, along with the results of electron microscopy
studies such as those by Palade [46,47], led to the idea that sheets are the main site for
protein biosynthesis in the ER. The relatively low membrane curvature and large lumenal
volume of sheets are optimal for both the binding of ribosomes or polyribosomes to the
bilayer and for the accessibility of chaperones to nascent peptides needed for folding and
post-translational modifications. In agreement with the idea that ribosome-studded sheets
of rough ER form a “protein factory” functional domain, cells that are specialised in secret-
ing proteins, such as pancreatic secretory cells, have a higher proportion of ER sheets than
cells that secrete very few proteins, such as epithelial cells and neurons [50]. Components
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of the translocon were also enriched in sheets [13]. Taken together, these results strongly
suggest that sheets are the primary location of protein biosynthesis in the ER.
Newly synthesised membrane and lumenal proteins need to fold properly and be
appropriately modified post-translationally, for example by the addition and subsequent
trimming of glycan chains and the formation of disulphide bridges (reviewed in [51,52]).
This process involves multiple ER-resident chaperones and enzymes which act in se-
quence to assist and monitor the correct folding and glycosylation status through the
calnexin/calreticulin cycle. Any proteins that fail to fold are recognised and removed from
this cycle, to be retrotranslocated out of the ER and degraded by the proteosome in a process
termed ER-associated degradation (ERAD) [51]. The load of misfolded proteins is closely
monitored, and if too many build up, the unfolded protein response (UPR) is triggered,
which leads to upregulation of the key ER-resident proteins required for protein folding
combined with inhibition in protein synthesis [53]. While the proteins involved in folding
and glycan addition are ubiquitously distributed throughout the ER, there is evidence that
certain key proteins in the quality control and ERAD pathways may be concentrated in
specialised structures called the ER-derived quality control compartment (ERQC) which is
localised next to the nucleus [52]. While the exact nature of this compartment and how it
is connected to the bulk ER remains unclear, its localisation depends on the microtubule
motor dynein [54].
Interestingly, prolonged ER stress has been seen to induce the reversible formation of
whorls of ribosome-free ER membranes that contained the Sec61 translocon and the key
UPR signalling enzyme PKR-like ER kinase (PERK), but not reticulons, CLIMP63 or the
lumenal marker calreticulin [55]. The whorls formed from vesicular/tubular structures
that budded from the ER via the COPII pathway (see below) and subsequently fused
and flattened. This is markedly different to normal conditions, where Sec61 is excluded
from COPII vesicles. These whorls may facilitate two UPR outcomes: inhibition of protein
translocation by segregating and inactivating translocons, and activation of PERK. The
whorls resemble the organised smooth ER (OSER) previously seen when certain ER proteins
such as HMG-CoA reductase or cytochrome b5 are over-expressed [56,57]. How whorls
and OSER relate to the ERQC is a key question to be addressed in the future.
2.2.2. ERES: Export Checks
Correctly folded lumenal and membrane proteins leave the ER at ER exit sites (ERES),
which are structurally distinct, ribosome-free puncta located in the rough ER network.
Exit sites consist of a cluster of vesicular-tubular membranes [58,59], continuous with
the ER membrane. In vertebrate cells, ERES are scattered throughout the network and
protein transfer from the ER to the Golgi relies on microtubule-dependent transport via the
dynein/dynactin motor protein complex [60]. The ERES themselves undergo short-range
movements on microtubules [61]. Two protein coat complexes, COPI and COPII, aid in the
formation and organisation of the exit sites as well as in protein transport. COPII forms
a scaffold to deform the membrane, regulates cargo entry into ERES [62], and remains
localised to ERES even after cargoes have departed [63–65]. COPI however, travels with
the cargo as it is transported away from exit sites [66], as does Rab1 [65]. The exact roles of
COPI in cargo trafficking away from the ER are unknown, but it may play a role in sorting
and delivering cargo to the Golgi apparatus [66,67].
The higher-order structure of ERES has only recently been identified using FIB-SEM.
Weigel et al. discovered that an interwoven network of narrow tubules (40–60 nm in
diameter) exist at exit sites, connected to the ER by a slightly narrower COPII neck [63].
Long, pearling tubules with COPI punctae were also found to extend from the exit sites,
along microtubules towards the Golgi apparatus. Pearled outlines are a hallmark of
longitudinal tension in tubular membranes [68] and may be the result of forces applied
by dynein/dynactin [60]. Such membrane pearling has been hypothesised as a precursor
to fission, transforming tubules into vesicles [69]. Dynein may be recruited to ERES
membranes via an interaction between dynactin p150 and the COPII components Sec23
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and Sec24 [70], but how the motor attaches to carriers once the coat is lost is an open
question. One potential route is via BicD2 and Rab6, which have been shown to recruit
dynein to ERES and drive their concentration in the perinuclear region [59]. Kinesin-1 is
also present on both ERES [61] and the transport carriers they produce [71]. Interestingly,
exit sites were also found to double in diameter in response to the accumulation of cargo,
while the diameter of nearby ER tubules was unaffected [63]. Together, these studies show
that ER exit sites are highly organised cargo export subdomains, capable of responding to
changes in cell requirements.
2.2.3. MCSs: Lipid Manufacture
Given that sheets are likely to be responsible for protein biosynthesis, could tubules
be responsible for lipid synthesis and calcium ion homeostasis? In support of this idea,
cells responsible for steroid synthesis, such as adrenal cortical cells, have proportionally
more ribosome-free smooth ER [72]. It has also been suggested that membrane contact sites
(MCSs) between the ER and other organelles may be more common in the ribosome-free
tubular region of the network, particularly those MCSs formed with the plasma membrane,
endosomes, lipid droplets and mitochondria [73–78]. The MCSs and relevant proteins
discussed in this review are shown in Figure 2. MCSs are tethered connections between
organelles, where the membranes are not fused, but separated by 5–30 nm [79–82]. Such
close proximity of the membranes enables the non-vesicular transfer of cargo between
the organelles [83]. MCSs are present between the ER and almost every other subcellular
organelle [38,81]. Their function, morphology, and dynamics are diverse and well-reviewed
(e.g., [84–86]). Here, we will focus on the links between MCSs and ER function and dynamics.
Lipid biosynthesis is known to occur primarily in the ER [87,88]. Using cell fractiona-
tion, enrichment of the machinery involved in lipid and sterol synthesis was discovered
in the ER membrane that is associated with mitochondria [89–91] and the plasma mem-
brane [92]. More recently, it has been shown that ER–plasma membrane contact sites
are required for the synthesis of phosphatidylcholine, an integral component of biologi-
cal membranes, in yeast [93]. Lipid metabolising machinery has also been found at the
leading edge of dynamic ER tubules [7] and in dynamic ER-derived vesicles that contact
many other organelles in Cos-7 cells [94]. The ER is also responsible for the synthesis
of neutral lipids [95]. Neutral lipids lack charged groups and therefore cannot easily
be integrated into lipid bilayers. Instead, lipid droplets are formed, which consist of a
phospholipid monolayer surrounding a core of neutral lipids. Exact details about the
formation of lipid droplets are still up for debate; however, it is now known that lipid
droplets are formed in the ER [96–98]. Neutral lipids gather within the lipid bilayer of
the ER, forming a lens between the inner and outer leaflets [97], before budding off into
the cytoplasm [99]. In plants, it has also been suggested that lipid droplets are formed
in specialised subdomains of the ER [100]. In addition to being formed in the ER, lipid
droplets can re-contact the ER once they have budded off [101]. The ER–lipid droplet
membrane bridges formed are proposed to facilitate the exchange of lipid metabolising
enzymes, without which large lipid droplets are not formed [102–104]. The discovery of
upregulated lipid metabolising machinery in the tubular ER, particularly at MCSs with the
plasma membrane, mitochondria and lipid droplets, suggests that these subdomains also
participate in lipid metabolism [7,89–92,94,95].
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Figure 2. Membrane contact site proteins that are discussed in this review. MCSs between the ER and the Golgi apparatus
(A), lipid droplets (LD, (B)), the plasma membrane (PM, (C)), peroxisomes (PO, (D)), early endosomes (Endo, (E)), late
endosomes/lysosomes (LE/Lyso, (G)) and mitochondria (Mito, (H)) are shown. The triple MCS between the ER, endosomes,
and mitochondria is also depicted (F). Orange proteins are those known, or thought to be, involved in lipid transfer and
blue proteins are calcium ion channels. Proteins with no clear function in relation to lipid or calcium ion transfer are
coloured light green (transmembrane) or lilac. The dotted line in H separates MCS-forming proteins (on the left of the line)
from proteins recruited to MCSs and those whose interacting partners are unknown or not included in this review. The
ER–mitochondrial MCS-forming mechanisms of mitofusin 2 and REEP1 are still unclear, however, both proteins may form
homodimers in order to tether the organelles [105,106].
2.2.4. MCSs: Lipid Exchange
Newly-synthesised lipids must be delivered from the lipid synthesis subdomains of
the ER to their final destination. Each membrane-bound organelle has a specific lipid com-
position [107] and therefore lipid transfer requirements are tailored to each organelle. Lipid
composition affects many properties of an organelle membrane, including its curvature and
the proteins recruited to both the cytoplasmic face of the organelle and the transmembrane
proteins [108]. Lipids are known to be transported from the ER to other organelles via
vesicular and non-vesicular transport mechanisms, such as lipid transfer proteins.
Lipid transfer from the ER to the Golgi apparatus occurs via a vesicular mechanism,
which forms part of the secretory pathway, and via monomolecular lipid transport medi-
ated by lipid transfer proteins at the ER–Golgi interface. In the vesicular transport route, the
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membrane leaves the ER via ERES (Section 2.2.2) and the same vesicles/tubular-vesicular
clusters that carry ER-synthesised proteins from the ER to the Golgi can also contain lipids
metabolised in the ER [109]. These lipids then continue along the secretory pathway to
reach their destination.
Lipid transfer proteins traffic lipids between organelles that are not connected by
vesicular transport pathways [83]. These transfer proteins are enriched at membrane con-
tact sites between the ER and the plasma membrane [110–116], Golgi apparatus [117–119],
and endosomes [120–125] (lipid transfer proteins at ER MCSs were recently reviewed
in [108]). Evidence has recently been discovered for three-way MCSs between the ER,
late endosomes, and mitochondria, via PDZD8, a protein that possesses a lipid transfer
domain and interacts with protrudin, a key component for ER motility (Section 3.1.2),
and Rab7 [126]. This three-way contact is hypothesised to facilitate lipid transfer between
these three organelles. Contacts between the ER and late endosomes/lysosomes involve
the ER-anchored VAP proteins (e.g., [82,127–129]), and these interactions are sensitive
to nutrient status [128,129]. Importantly, contact sites between early endosomes and the
ER in low cholesterol conditions facilitate the transfer of cholesterol from the ER to the
multivesicular body, where it is needed to drive endosomal sorting via the formation of
intralumenal vesicles (ILVs) [120]. As an aside, ER-early endosome contacts also facilitate
ILV formation by providing sites where the ER-localised protein tyrosine phosphatase
1B dephosphorylates endocytosed, active growth factor receptors such as the epidermal
growth factor receptor, which is required for EGFR to be sorted into ILVs [130]. This may
be why motile early endosomes have been seen to pause at ER tubules [74]. Bidirectional
cholesterol transfer also occurs at contacts between the ER and late endosomes/lysosomes
(reviewed in [86,131]), and these sites involve a number of proteins implicated in recruiting
microtubule motors (see below).
Peroxisomes and the ER must exchange lipids as the synthesis of some lipids, for
example, ether phospholipids, begins in peroxisomes but is completed in the ER [132,133].
The lipid transfer protein VPS13D has been discovered at both ER–peroxisome and ER–
mitochondria contacts, where it interacts with Miro [134], and another, VPS13A, has
been found at ER–mitochondria contacts [124], and this lipid transport has been shown
to be important for peroxisome biogenesis [135]. The machinery involved in creating
ER–peroxisome MCSs has recently been discovered [136] and there is some evidence
for non-vesicular ER to peroxisome lipid transport [137]. Similarly, phosphatidylserine
must be transferred from the ER, where it is synthesised, to the mitochondria, where it is
converted to phosphatidylethanolamine [138–140]. It has been shown that this lipid transfer
occurs even without cytosolic phospholipid exchange proteins or small vesicles [139,140]
and is therefore likely to happen via lipid transfer proteins at ER–mitochondria MCSs.
ERMES (ER–mitochondria encounter structure), a protein complex found in yeast, has been
proposed as a tether-forming complex between the two organelles [141–144]. This complex
may also transfer lipids at contact sites, via transport proteins such as Lam6/Ltc1. Lam6
interacts with the mitochondrial proteins Tom70 and Tom71 at ER–mitochondrial MCSs
and is known to transfer sterols in vitro [145–147]. Likewise, PDZD8 may fulfil a similar
role [126].
These non-vesicular pathways are a significant mechanism of lipid trafficking. Indeed,
it was found that the rate of lipid transfer from the ER to the plasma membrane does
not appreciably decrease when vesicular pathways are blocked [148–151], indicating that
non-vesicular transport alone can sustain the required lipid transfer to the plasma mem-
brane. As MCSs between the ER and other organelles, particularly the plasma membrane,
mitochondria, and endosomes [73–78], preferentially form in the tubular ER network, these
findings suggest that lipid transfer occurs primarily in the tubular ER.
2.2.5. MCSs: Calcium Control
Another important function of the ER is calcium ion sequestration and release. Ca2+ is
an important signalling molecule, the concentration of which affects not only the function
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of the ER but also a wide range of other pathways, including mitochondrial metabolism
and apoptosis [152–154]. Chaperone proteins within the ER such as calnexin [155], calretic-
ulin [156], and protein disulphide isomerase [157], among others, bind to Ca2+ and their
function as chaperones in protein folding is dependent on the calcium ion concentration in
the ER [158,159]. The accumulation of improperly folded proteins leads to ER stress and
activates the unfolded protein response (UPR), which can either restore ER homeostasis or
induce apoptosis, depending on the cellular circumstances (reviewed in [160]). Therefore,
regulation of Ca2+ concentration is imperative for normal cell function.
Calcium ions are released from the ER by transmembrane receptors, primarily the
ryanodine receptor (RyR) and the inositol 1,4,5-trisphosphate receptor (IP3R), in response
to intracellular cues. Mitochondria are located in positions close to IP3Rs [161,162] in order
to take up Ca2+ ions upon their release. Calcium ions are necessary for mitochondrial
metabolism, including ATP production and reduction of pyridine nucleotides [152,153].
In order to transfer Ca2+, a complex is formed between the ER-resident IP3R and voltage-
dependent anion channel 1 (VDAC1) in the outer mitochondrial membrane [161,163,164].
Grp75, a cytosolic protein, forms a tether between the channels to facilitate Ca2+ transfer to
the mitochondria [165]. Mitofusin 2 is also implicated in both ER–mitochondrial tethering
and mitochondrial calcium uptake [105], although there is some debate as to its exact role
(reviewed in [166]). MCSs between the ER and mitochondria, which primarily occur in the
tubular ER, are clearly of great importance for calcium ion homeostasis [85]. IP3Rs also
mediate calcium transfer to lysosomes at ER–lysosome MCSs [167].
Upon ER calcium ion depletion, an influx of Ca2+ from extracellular sources is required
to replenish the lumenal Ca2+ concentration. Transport of Ca2+ into the cell is accomplished
by the cooperation of STIM1 and Orai1. After calcium stores have been depleted, the ER-
resident protein STIM1 [168] and the plasma membrane calcium channel, Orai1 [169], are
recruited to ER-PM MCSs [170] where they form a complex [171]. Orai1 is a calcium release-
activated calcium (CRAC) channel which is opened when the interaction with STIM1
occurs [172]. This process of Ca2+ influx is known as store-operated calcium entry (SOCE).
The Ca2+ entering the cell is then transported into the ER via sarco/endoplasmic-reticulum
Ca2+ ATPase (SERCA) pumps. These pumps expend ATP to transport calcium ions against
the Ca2+ concentration gradient into the ER, refilling lumenal calcium stores [173–175].
From the work summarised here, it is apparent that MCSs with mitochondria and the
plasma membrane are responsible for calcium ion release from the ER and influx from the
extracellular region respectively. STIM1 also plays an important role in ER dynamics, by
linking ER tubules to growing microtubules to form tip attachment complexes (TACs), as
described in Section 3.1.3.
2.2.6. MCSs: Control of Membrane Fission and Fusion
A fascinating aspect of MCS function is that in several cases, they act as hotspots for
membrane fission or fusion of the organelle bound to the ER. For example, mitochondrial
fission occurs at points where they contact ER tubules and become constricted before
the fission protein Drp1 is enriched [38,73]. Drp1 is always accumulated at, or next to,
ER–mitochondrial contacts. Interestingly, Drp1 has recently been shown to facilitate ER
tubule formation, and to be localised on all ER tubules at low levels, as well as generating
sites for mitochondrial–ER interaction and mitochondrial fission [42]. However, this role in
generating ER tubules does not require Drp1′s GTPase activity, whereas that is essential
for mitochondrial fission [42]. Mitochondrial fusion has also been shown to occur more
frequently when mitochondria are attached to the ER [38].
As mentioned above, the ER also forms contacts with early endosomes, and these can
also be the site of endosome fission [176]. One isoform of the microtubule-severing protein
spastin localises on the ER membrane, and it interacts with the early endosomal ESCRT
protein IST1 at ER-early endosome contacts to drive endosomal tubule fission and sorting.
Disrupting this interaction led to the missorting of lysosomal enzymes and lysosomal
defects, which is likely to be the underlying reason why spastin mutations cause hereditary
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spastic paraplegia [177]. Another ER protein, reticulon 3L, has recently been shown to
be recruited to ER–endosome contact sites by Rab9 and promote endosome maturation
and sorting [178], likely explaining why endosome maturation correlates with enhanced
interactions with the ER [75]. It will be interesting to determine if these are the same or
different pathways.
More than 90% of late endosomes/lysosomes are associated with the ER [38,179] and
80% of endosomal fission events happen when associated with the ER [176]. Retromer
drives the sorting and recycling of material from the late endosome to the Golgi apparatus,
and the scission of retromer tubules happens at points of contact with the ER and requires
an ER membrane protein, TMCC1 that accumulates at ER–endosome contact sites, the
actin-binding protein coronin 1 [179], and the WASH complex [127] and its interactor,
strumpelin [177].
3. ER Dynamics
The ER is not only complex in its organisation, but also in its motion. Progress in
the understanding of ER dynamics has been slower than that of ER morphology as the
narrow tubules and constant motion and rearrangement of the network make the ER
challenging to image. ER dynamics in mammalian cells can be categorised into three
types: oscillation of established network elements; the dynamics of particles within the
ER lumen or membrane; and generation of new network elements (see Figure 3). The
purpose of ER dynamics is still unclear, but the predominant theory is that oscillations
accelerate the processes carried out in the ER by facilitating the movement of lumenal and
transmembrane particles [25,180,181].
Figure 3. Schematic depicting the dynamics of the ER network. Fluctuations of the tubules, junctions,
and sheets of the ER are shown with black lines and arrows. Tubules, junctions, and sheet edges
oscillate laterally (within the plane of the page) and vertically (perpendicularly to the plane of the
page). Vertical sheet fluctuations, as shown by the black arrows, are also thought to occur. The
transmembrane and lumenal proteins also move, as shown in the inset. Motor proteins bind to the
ER and move along microtubules to draw out new tubules from the existing network (see top right).
3.1. Cytoskeletal Control of ER Dynamics
The ER constantly rearranges its spatial organisation. The impressive dynamics of
the ER were observed in living cultured CV1 cells [182], newt lung cells [23], and growth
cones in cultured neurons [183] long before the discovery of green fluorescent protein
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(GFP), by the use of the lipophilic dye DiOC6. New tubules can be drawn out from the
existing network and fused to neighbouring tubules or junctions to create new connections,
and network polygons can form and disappear ([182]; Figure 4). This microtubule-motor-
driven movement is described in Section 3.1.1. The proportion of the network in sheets
and tubules can also change dynamically. ER sheets reorganise into tubules when ribo-
somes are stripped from their surface with puromycin [45]. As described below, inhibiting
microtubule-based tubule movement can in turn increase the proportion of sheet-like
regions. Entry into mitosis has been reported to trigger sheet expansion [37,43,184], al-
though other studies have demonstrated enhanced mitotic tubulation [45] that is driven by
REEPs 3 and 4 [185]. Such dynamic reorganisation may help the organelle to sample the
cellular volume rapidly [1] and respond to changes in cellular requirements and nutritional
status (Section 3.1.3). ER-associated microtubule motors are not the only means by which
the ER interacts with the cytoskeleton, and in the following sections, we describe how
tubules can also be extended by interactions with growing microtubules via tip attachment
complexes (TACs) and by association with motile MCSs. Static interactions of ER tubules
with microtubules and the role played by the actin cytoskeleton are also outlined.
Figure 4. Early endosomes associate dynamically with the ER. A small endosome (red and white arrows) transiently
associates with the ER and extends an ER tubule (blue arrow). When released from the endosome, the ER tubule retracts.
The moving endosome/ER tubule briefly interacts with another endosome (yellow arrow). Other endosomes interact
statically with ER tubules (asterisks). Images of GFP Rab5 (pseudocoloured red for easier visualisation of the small vesicles)
and mCherry ER marker (LongER, [20]) (cyan) were collected simultaneously at 10 fps in wide-field mode on a DeltaVision
OMX (A*STAR Institute of Medical Biology, Singapore) by V. Allan. Scale bar = 2 microns.
3.1.1. Microtubule Motors Drive ER Dynamics
Early studies using DiOC6 revealed that ER tubules in the cell periphery often co-
aligned closely with microtubules [23,183,186], as confirmed in many subsequent studies
(e.g., [21,38,187]). Ring rearrangement and tubule branching also occur in association with
microtubules [38]. The depolymerisation of microtubules completely inhibited ER tubule
and network dynamics in VERO cells [20] and increased the amount of ER in sheet-like
structures and reduced the tubular network [20,37,38,186,188]. Super-resolution imaging
in live cells has shown that these sheets actually consist of a mixture of morphologies, in-
cluding thick sheets, thinner sheets containing nanoholes, and dense tubular networks [33],
suggesting that microtubules not only control the position of the ER network but also
contribute to the detailed organisation of ER membrane domains.
Direct visualisation of ER-like tubules extending along microtubules came first from
in vitro assays using extracts from CV1 cells [189] or interphase Xenopus eggs [190] where
video-enhanced differential interference contrast microscopy revealed membrane tubules
sliding along microtubules. The Xenopus networks were shown to be ER by antibody
labelling and the presence of polysomes on the membrane surface [19]. Motility brought
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tubules in contact with each other, resulting in tubule fusion [19,20,189] that was atlastin-
dependent [184]. In addition, both smooth and rough ER from rat liver formed motile
networks when combined with interphase Xenopus egg cytosol, demonstrating cross-
species conservation of motility and membrane fusion [191]. However, if the concentration
of membrane is high enough in vitro, an ER tubule network can form in the absence of
microtubules [192]. The motor-driven sliding of ER tubules along microtubules has since
been visualised many times using fluorescence microscopy (e.g., [20–22,38]).
Since microtubules are oriented in most cultured non-neuronal cells with their dy-
namic ‘plus’ ends towards the cell periphery, rapid outward ER tubule sliding requires a
plus-end-directed microtubule motor. The founding member of the kinesin superfamily,
kinesin-1, is responsible for this motility [20,193,194]. Inhibition of kinesin-1 not only
inhibited outward tubule movement but also increased the proportion of ER sheet regions
in the cell periphery [20]. Given that sheet-like regions can consist of either accumulated
fine tubular networks [34] or sheets containing nanoholes [33], it will be interesting to
see if these sheets correspond with either type of structure, or if there is a mixture of
morphologies, as seen after nocodazole treatment [33]. Most kinesin-1 in animal cells is
tetrameric, comprising two identical motor (KIF5) subunits and two identical KLCs [195].
Vertebrates express three KIF5 genes: KIF5B is expressed ubiquitously, while KIF5A and
C are neuronally enriched. We will return to KIF5A later since mutations cause neurode-
generative diseases (Table 1) [195]. There are four KLC genes, with KLCs 1, 2, and 4 being
widely expressed. KLC1 exists in multiple alternately spliced forms, with KLC1B being
required for ER motility [20,193].
An important outstanding question is the identity of the kinesin-1 receptor on the ER.
Several candidates have been proposed, but there are caveats with all of them. It is possible
that there are different receptors in neuronal vs. non-neuronal cells, and in different tissues.
Kinectin was identified using a function-blocking monoclonal antibody [196] and binds
to the KIF5 C-terminus [197]. Kinectin has been implicated in the regulation of focal
adhesion dynamics during chemotaxis by promoting ER targeting to focal adhesions at
the cell’s leading edge [198,199]. Interestingly, Rab18 is required for this process and forms
a ternary complex with kinectin and kinesin-1 [198]. However, kinectin knock-out mice
had no phenotype, with normal ER (and other organelle) distribution in KO MEFs [200].
Furthermore, in cultured neurons, the ER extends all along axons, yet kinectin is only
observed in the cell body [194], in keeping with its proposed role in maintaining ER
sheet spacing [13]. Nevertheless, the siRNA depletion of kinectin decreased ER network
dynamics in Cos-7 cells [26]. Intriguingly, Rab10, is also implicated in regulating ER
tubule formation [7] and has been reported to form a complex with JIP1, a neuronally
expressed kinesin adaptor, and KLC1, to promote the transport of secretory vesicles during
neuronal polarisation and axon growth [201]. Whether this complex is involved in ER
tubule extension in neurons, and whether the Rab18-kinectin-KIF5B complex is needed for
ER tubule extension in non-migrating cells are open questions.
Another candidate ER kinesin-1 receptor is p180, which shares homology with kinectin’s
kinesin-1 binding domain [202], and which, like kinectin, has also been localised to central
sheet regions in non-neuronal cells [13,16,194]. In cultured neurons, however, p180 localised
not only to sheets in the cell body, but also to tubules in axons, but not dendrites [194], a
localisation consistent with KIF5 binding. However, it is likely to be acting as an anchor
between the ER and microtubules rather than as a kinesin-1 receptor (see Section 3.1.3).
There are two further candidate kinesin receptors. Protrudin (gene name ZFYVE27) is
an ER-resident kinesin binding protein with a key role to play in generating motile late
endosome–ER MCS motility, as described in Section 3.1.2. However, it is expressed at
very low levels (undetected in the HeLa cell proteome [203]), and while its depletion with
siRNA leads to late endosome clustering at the cell centre [204,205], it is not clear what
effect this has on ER distribution. Finally, the ER-localised transmembrane DNA-J-domain
protein B14 has been shown to interact with KIF5B to generate a site for SV40 virus release
from the ER [206], but its involvement in normal ER dynamics remains to be tested.
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Given that the ER extends outwards from the nuclear envelope towards the cell
periphery, an unexpected finding was that ER tubules moved towards microtubule minus
ends in interphase Xenopus egg extracts, driven by dynein [19,184,190,207,208]. This fits
with the requirement for dynein at the nuclear envelope to drive pronuclear migration,
which can be reconstituted in these extracts [209]. However, exclusively dynein-driven
ER motility continued even in extracts made from embryos after the fifth cell division:
kinesin-dependent ER movement was only seen when cytosol from a tadpole cell line was
used [187]. Recent work has provided a satisfying explanation for this phenomenon [210]:
the perinuclear pool of ER that accumulates due to dynein activity is needed to assemble
the large nuclei seen in early embryos (sea urchin and Xenopus embryos in this study).
Furthermore, expressing additional reticulon 4b decreased the size of nuclei, presumably
by reducing the formation of ER sheet regions [210]. Xenopus egg extracts have also
revealed cell cycle-dependent changes in ER dynamics, with dynein-driven movement
being inhibited in metaphase-arrested extracts [184,190,207] while myosin V-driven ER
motility on actin filaments was activated [211]. ER sheets accumulated [184], as has been
reported in mitotic HeLa cells [37], although other studies contradict this [45,185].
Dynein is not just an important ER motor in embryonic cells. Around half of rapid
ER tubule movements in VERO cells occurred towards the cell centre, and were dynein
driven [20]. Furthermore, the inhibition of dynein led to a profound accumulation of ER
sheets in the cell periphery without affecting outwards, kinesin-driven movement [20].
Similarly, both dynein and kinesin-1 drive ER tubule motility in axons [194] and den-
drites [212,213] of cultured rodent hippocampal neurons. As yet, the receptor for dynein
on the ER has not been identified in any system, unlike for ERES (Section 2.2.2).
A final example of microtubule-motor-driven movement involving the ER is provided
by nuclear migration and positioning. As well as the pro-nuclear migration mentioned
above, kinesin and dynein coordinate nuclear positioning in many different situations,
such as during neuronal nuclear migration during brain development [214] and nuclear
movement at many stages of C. elegans development [215]. Dynein at the nuclear enve-
lope is important for centrosome separation in late G2/prophase, and facilitates nuclear
envelope fragmentation (reviewed in [216]). Kinesin-1 is also involved in centrosome and
nuclear positioning in non-polarised cells, where it is recruited to the nuclear envelope
by RanBP2 and BICD2 [217]. Interestingly, nesprin 4 is specifically expressed at the outer
nuclear envelope in polarised epithelia, where it recruits kinesin-1 which then translocates
the nucleus to the base of the cell [218].
3.1.2. MCS-Mediated ER Dynamics
In addition to tubule extension driven by motors directly at the ER membrane, ER
dynamics can be caused by ER membrane contact sites with early and late endosomes, lyso-
somes, and mitochondria [22,26,38,74,75,84–86,204,219,220] that move along microtubules.
This is an example of a process referred to as ‘hitchhiking’, where one organelle provides
the motor and drives the movement of another cargo that is not motile by itself [38,221,222].
In fact, early work on ER tubule movement identified morphologically-distinct motile
domains at the tips of some moving ER tubules [182,191]. However, there is clear evidence
from transmitted light microscopy and DiOC6 labelling that ER tubules themselves can
translocate directly along microtubules, without the need for hitchhiking with another
organelle [19,182,183,190].
Around half of Rab5-positive endosomes in Cos-7 cells are attached to the ER during
imaging [75], and when imaged at low frame rates (1 frame per 1.5 s) appeared less
motile than ER-associated lysosomes [219], and less likely to cause ER tubule mobility [26].
However, live imaging at the rapid frame rates needed to capture fast early endosome
movement has revealed that moving endosomes can translocate towards an ER tubule,
grab it and continue moving, pulling out an ER tubule behind them ([74]; Figure 4).
As early endosomes move primarily towards the cell centre, driven by dynein [74,223],
hitchhiking on early endosomes may account for some of the dynein-dependent ER tubule
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extensions [20]. How dynein and kinesins are recruited to early endosomes, and the role of
kinesin-1 in their movement, is not fully understood.
Recent work suggests that 30–50% of ER tubule extension events are driven by hitch-
hiking on late endosomes/lysosomes moving along microtubules, while 40% of tubules
moved along microtubules independently, and the remainder were mediated by TACs or
dTACs (see below) [26,38,219]. Surprisingly, almost all lysosomes were associated with,
and moved with, the ER network [219]. Lysosomes that were imaged before, during, and
after a hitchhiking event were seen to slow down when attached to ER tubules [204,219],
possibly because there was less drag counteracting the force generated by the lysosomal
motors when not extending an ER tubule. Two ER-resident proteins involved in phos-
pholipid synthesis, PIS and CEPT1, which have previously been shown to be at the tips
of motile tubules along with Rab10 [7], were associated with LE/lysosome hitchhiking
events [26].
Again, dynein and kinesin-1 are the major motors driving late endosome/lysosome
movement, and there are multiple ways in which they are recruited and controlled, some of
which involve interactions with the ER (reviewed in [128,129]). Dynein can be recruited via
RILP and Rab7 (in the presence of high cholesterol levels); ALG2 and TRPML1 (regulated
by PI(3,5)P2 and calcium); or JIP4 and TMEM55B (promoted by starvation, which increases
TMEM55B transcription via mTORC1) [128,129]. Kinesin-1 is recruited by SKIP and Arl8
(regulated by BORC), or FYCO1 and Rab7 (regulated by PI(3)P and involving protrudin at
the ER: see below), and both linkages are via KLCs [128,129]. An open question is whether
these multiple mechanisms function in parallel on the same organelle, or whether there
is spatial selection (e.g., on specific membrane subdomains), or switching depending on
metabolic status, or other inputs.
If only 30–50% of ER tubules move in association with late endosomes/lysosomes,
how important is this ER hitchhiking for ER organisation overall? Two recent studies have
demonstrated that in Cos-7 cells at least, the answer is—very. Disrupting ER-late endosome
MCSs by RNAi-mediated depletion of VAPA (which binds ORP1L to anchor LE to ER
via Rab7: [128]) also disrupted ER morphology and reduced the extent of ER tubules and
network complexity, especially at the periphery [26,219], with the knockdown of all ER VAP
family members (VAPA, VAPB and MOSPD2) giving a stronger phenotype [26]. In addition,
manipulating the motors present on late endosomes/lysosomes provided a useful means
of triggering inward or outward endosome movement, which led to a reduction or increase
in peripheral ER tubules [26,219] and network dynamics [26]. Interestingly, the depletion
of SKIP or Arl8 caused major changes in the ER network, suggesting that this is the major
route for kinesin-1 recruitment for this process, rather than protrudin/FYCO1 [219].
Protrudin, the product of the ZFYVE27 gene, is a multispanning transmembrane
ER protein that has a plethora of interactors, both at the ER, and at late endosomes. At
the ER, it binds to the ER shaping proteins atlastin, REEPs 1 and 5, reticulons 1, 3, and
4, and also interacts with VAP via an FFAT motif ([224]; reviewed in [225]). It can also
bind to late endosomes via its Rab-binding domain, which binds Rab7-GTP, and an FYVE
(Fab-1, YGL023, Vps27 and EEA1) domain, which binds to the late endosomally enriched
phosphotidylinositol 3-phosphate (PI3P) [204,225]. Crucially, it also binds to all KIF5
family members, although the interaction is strongest with KIF5A [226], which is striking
considering both protrudin and KIF5A (but not KIF5B or C) can cause hereditary spastic
paraplegia when mutated (Table 1). Over-expression of either protein caused the formation
of protrusions in non-polarised cells [226], hence protrudin’s name [225], while siRNA-
mediated depletion led to an expansion of CLIMP63-labelled sheet-like regions into the
cell periphery [224].
Given protrudin’s potential to bind to the late endosome, Raiborg and coworkers inves-
tigated if it was involved in MCS formation and found that was indeed the case [204]. Fur-
thermore, overexpression of protrudin led to an accumulation of late endosomes/lysosomes
at the cell periphery, a phenotype that had previously been seen for FYCO1, another PI3P
and Rab7-binding protein, and which was found to interact with protrudin [204]. Imag-
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ing of FYCO1 and protrudin in living cells revealed that moving FYCO1-positive late
endosomes interacted with protrudin at the ER, pausing or slowing down while they did
this, then detached and moved off more rapidly. Protrudin binds KIF5 and FYCO1 binds
KLC, and the expression of protrudin increased the amount of KIF5 found associated with
FYCO1, leading to the model that kinesin is passed from protrudin to FYCO1 on the late
endosome during ER-late endosome association, so activating late endosome movement
once they break free of the ER. While this model is appealing, more formal proof is needed.
What is clear though, is that both protrudin and FYCO1 are important for axon exten-
sion [129,195,204,227]. Protrudin and FYCO1-mediated late endosome translocation to the
cell periphery has also been shown to be important for invadopodia formation, where late
endosomes deliver the matrix protease MT1-MMP for secretion, which is necessary for
cancer cell migration [205].
Importantly, the late endosome/lysosome position is controlled by nutritional statuses,
such as cholesterol and amino acid level, which in turn regulate dynein and kinesin-1
recruitment or activity [128,129,228]. This regulation has recently been shown to have a
major impact on ER dynamics and distribution within the cell [26,219]. Serum starvation
led to a less mobile ER network and reduced late endosome/lysosome motility, leading to
a less complex ER network in the cell periphery with fewer tubule junctions [26]. Lu and
coworkers found that a 4 h serum starvation led to late endosome/lysosome clustering, and
a reduction in the proportion of tubular ER, as did cholesterol enrichment [219]. In contrast,
24 h starvation or cholesterol depletion triggered peripheral localisation of endosomes with
no effect on ER tubules [219].
The protrudin-mediated ER–endosome/lysosome contact pathway is also influenced
by nutritional status. The neuronal isoform of carnitine palmitoyltransferase 1, CPT1C, is
an ER protein that is regulated by malonyl-CoA levels and mutated in HSP [228]. Recent
work has revealed that CPT1C is needed for proper neuronal growth and controls the
transport of late endosomes/lysosomes to the axon tip, and this needs its ability to bind
malonyl-CoA [228]. It interacts with protrudin, and expressing it in HeLa cells increased
the proportion of outward-moving FYCO1-labelled late endosomes if malonyl-CoA was
present, but reduced movement to below control levels if malonyl-CoA was depleted.
However, unlike protrudin, CPT1C was present, but not enriched, at ER–lysosome contacts,
suggesting that it regulates the protrudin–FYCO1–kinesin-1 interaction rather than being
directly involved. The authors suggest that in the presence of malonyl-CoA, CPT1C
promotes the transfer of kinesin-1 from protrudin to FYCO1 on late endosomes/lysosomes,
thus promoting their outward movement in neurons [228]. However, as mentioned above,
this kinesin transfer model requires further testing.
Mitochondria are known to interact extensively with the ER in live cells [22], and
motile mitochondria can extend ER tubules [22,38]. ER-associated mitochondria preferen-
tially localised to acetylated microtubules [22], which are the preferred track for kinesin-1
(e.g., [229]), which is a motor for both mitochondria (e.g., [230]) and the ER. Mitochondria
were also seen to interact with lysosomes, and the moving lysosome could pull out a
thin tubule from the mitochondrion [38]. As similar thin tubules were found to extend
from mitochondria at points of ER contact via the action of KIF5B and its mitochondrial
receptor Miro1 [230], it prompts the question as to whether the PDZD8-induced three-way
MCSs between ER, late endosomes, and mitochondria could be involved in both processes.
However, this complex interaction essentially immobilised the organelles [126].
MCSs are clearly vitally important for many aspects of ER function, metabolism,
and overall dynamics. This makes it challenging to interpret alterations seen following
experiments designed to disrupt one aspect of MCS function. This is exemplified by experi-
ments where Rab7a function—needed for late endosome/lysosome MCS, and involved
in recruiting both kinesin-1 and dynein to endosomes—was disrupted. Rab7a depletion,
or expression of a GDP-locked Rab7a, led to an accumulation of CLIMP63-labelled sheet-
like ER at the cell periphery, and activation of the ER stress response [231]. Mateus et al.
hypothesise that the structural change is caused by ER stress, rather than changes in ER
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dynamics [231]. Indeed, there are many ways in which stress can influence MCS and the
ER (reviewed in [85]). Monitoring ER stress levels will be an important control in future
studies (e.g., [219]).
3.1.3. Motor-Independent ER-Microtubule Interactions
It was clear from early studies that three kinds of ER–microtubule interactions exist:
motor-driven translocation of ER tubules, static interactions, and the attachment of ER
tubules to growing microtubule tips [23]. The latter interaction drives tubule extension via
the formation of ‘tip attachment complexes’, or TACs, first seen in Xenopus egg extracts [232].
In a variety of cultured cells, motor-driven sliding was seen to predominate over TACs
and static interactions between ER tubule tips and microtubules [20,21,23,38], although the
percentage differed between cell types [21]. TACs consist of the transmembrane ER protein
STIM1 (stromal interaction molecule 1), which interacts with the MT plus-end-tracking
protein EB1 [21]. STIM1 interacts with Orai1 at the plasma membrane upon depletion of ER
calcium stores to permit calcium transfer from outside the cell into the ER (see Section 2.2.5).
Interestingly, triggering this process prevented STIM1 tip tracking [21]. While the presence
of a TAC did not change the rate of microtubule growth and shrinkage, it reduced the
likelihood of the microtubule undergoing a catastrophe (starting to depolymerise) [232]. ER
tubules can also be extended by attaching to a depolymerising microtubule via a dTAC [38];
the composition of ER dTACs is not known.
Why have two methods for transporting the ER towards the cell periphery? In the
case of Xenopus embryos, although kinesin-1 is present on the ER, it is not active until later
in development [187]. Instead, the ER network distributes throughout the cytoplasm via
the combined activity of dynein pulling it towards the nucleus and centrosome, and TACs
extending it outward as microtubules polymerise [184]. In cultured cells, TACs would
ensure the ER reaches right to the cell edge. In contrast, kinesin-1’s preference for stable
microtubules as tracks, perhaps because they have less MAP7 bound to their surface, means
it translocates poorly to the end of newly-polymerised microtubules [229]. An important
role for STIM1-EB1-mediated ER localisation has been demonstrated in neuronal growth
cones, where STIM1 is needed for the orientation of microtubules and ER that is essential
for a growth cone to move towards a growth factor gradient [233].
The ER can also attach statically to microtubules, either via tubule tips, junctions, or
along the length of the tubule [187,232]. Static links between the ER and microtubules may
be formed by the previously mentioned proteins CLIMP-63 [15], p180 [16,194], REEP1 [17],
and Sec61β [234]. These links have been hypothesised to regulate ER network tension and
positioning [235]. It is also possible that ER attachment may stabilise microtubules, as has
been seen for p180 in axons [194]. One problem with assessing this is that over-expression
of a microtubule-binding protein may cause stabilisation (e.g., [16,234]) that might not
be seen at endogenous levels. However, this potential reciprocity between ER tubules
and microtubules will be important to consider in the future, not least because stabilised
microtubules would be ideal tracks for kinesin-1 transport of other ER tubules.
3.1.4. ER Interactions with the Actin Cytoskeleton
In animal cells, microtubules play the dominant role in remodelling the ER via the
surprisingly varied mechanisms described above, whereas in plants, algae, and some fungi,
actin-based motility is key (reviewed in [236]). Cytoplasmic streaming, the myosin-driven
directional flow of the cytoplasm, also plays a role in plant cell ER dynamics [237,238].
Interestingly, a novel ER and microtubule-associated compartment (EMAC) has been iden-
tified in plants that is anchored on microtubules, thereby resisting this flow [239]. Similarly,
stable tubular ER junctions have also been observed to associate with microtubules [240].
A surprising need to anchor the ER has also been seen in C. elegans nematodes, where
the loss of an ER and nuclear envelope-localised nesprin, ANC-1, leads to uncontrolled
streaming of the ER, mitochondria, and lipid droplets due to forces generated as the worm
crawls [241]. However, it is not yet clear what cytoskeletal component ANC-1 binds to.
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In animal cells, myosin-V-driven ER motility may contribute to short-range ER move-
ment (e.g., [211,242]). Furthermore, filamin proteins may bind the ER to actin in mouse
embryonic fibroblasts [243] and interactions between the ER and actin filaments via myosin
1c may stabilise sheets [188]. The degree of reliance of the ER network on the actin cytoskele-
ton differs between cell types, since depolymerising actin filaments with cytochalasin had
little effect on ER network distribution in VERO cells [20], while in the epithelial-like cell
line Huh-7, actin depolymerisation resulted in smaller, less abundant ER sheets at the cell
periphery and irregular ER positioning, with large regions of the cells devoid of the or-
ganelle [188]. Furthermore, when microtubules are depolymerised, a slow, actin-dependent
retraction of the ER towards the cell centre is seen in some [23,186,244] but not all [20]
cultured cell types, demonstrating that ER–actin interactions influence ER morphology.
Importantly, super-resolution live-cell imaging has revealed microtubule-independent ER
tubule extension [38], which may well be due to actin-based motility.
3.2. Network Fluctuations
The tubules, junctions and sheets that make up the endoplasmic reticulum fluctuate
over time. Even the established elements of the network that are not being actively
rearranged are not stationary, but rather oscillate around a position. Given the complex
morphology and fast dynamics of the ER, quantifying ER motion is a current challenge in
the field.
A widely accepted measure of dynamics is the mean squared displacement (MSD).
The MSD is a measure of how far an object is expected to travel over a specified time. To
calculate the MSD, firstly the difference in position between the object at an initial time and
the object at a later time is found. Each pair of points separated by the same time difference
(or lag time) is considered, and the mean difference in position for all of these pairs gives
the MSD at that particular lag time. Mathematically, the MSD, 〈∆r2(τ)〉, is defined as:
〈∆r2(τ)〉 = 〈(x(t + τ) − x(t))2 + (y(t + τ) − y(t))2〉, (1)
where x(t) and y(t) give the position of the object at time t and τ is the lag time. Fitting a
power law to the MSD allows the motion to be described as diffusive, sub-diffusive, or
super-diffusive. Diffusion, or Brownian motion, describes processes such as the gradual
mixing of regions of high and low concentrations to form an even distribution. MSDs for
diffusive motion follow 〈∆r2(τ)〉 ∝ τ. Anomalous diffusion is the term used to describe
cases in which the MSD is not diffusive. Super-diffusion describes active transport, such as
motor protein-driven motion, and the MSDs follow 〈∆r2(τ)〉 ∝ τα where 1 < α < 2. On the
other hand, sub-diffusive motion is associated with motion in a crowded environment and
results in MSDs with exponents α < 1. By tracking points in the ER network and calculating
the MSDs of these trajectories, information about the dynamics of individual components
of the ER has been elucidated. ER junctions have been found to move sub-diffusively, in
a microtubule-dependent manner [245]. Nocodazole treatment reduced the number of
diffusive and super-diffusive junctions, indicating that interactions with motor proteins
may be the cause of the directed junction motion. Tubules in the ER network oscillate
sub-diffusively in general, with an average MSD exponent of 0.5 [25]. This result is in
agreement with the theoretical prediction of 〈∆r2(τ)〉 ∝ τ1/2 for semi-flexible polymers
oscillating thermally in a viscous medium [246]. These results indicate that the movement
of the network is constrained, which is consistent with motion in a crowded environment
such as the cytoplasm.
Recently, the full contours of individual tubules have also been tracked, resulting in a
more detailed description of ER tubule dynamics [27]. The distributions of perpendicular
displacements from the mean tubule backbone position were found for points along the
tubule contour. The asymmetry, or skewness, of these distributions was calculated. Sig-
nificant skewness indicated active, driven dynamics, whereas positions with negligible
skewness described points oscillating thermally, without any active influences. The ma-
jority of points oscillated thermally, however, one-third of the points tracked fluctuated
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actively. Dynamic constrictions and bulges in the diameter of ER tubules have also been
observed [38,181], although the characteristics of these oscillations are yet to be analysed in
depth. As a result of both the MSD and contour tracking studies, ER tubules are thought to
oscillate sub-diffusively in general, with active dynamics occurring occasionally along the
tubule backbone. The sub-diffusive fluctuations are likely to be caused by the motion and
crowding of the cytoplasm, whereas active dynamics may be caused by motor proteins or
membrane contact sites with trafficking organelles.
Sheet dynamics have not been studied in as much detail as tubular dynamics. This is
probably due to the difficulty in quantifying the motion of lamellar objects, particularly
those within living cells. In particular, lamellar regions of the ER are often located in the
thicker parts of the cell near the nucleus, in which out-of-focus light from other imaging
planes makes capturing a video showing just one layer of ER sheets challenging. Even
with clear videos showing ER sheets, quantifying the dynamics of lamellar membranes is
challenging due to the lack of accepted methods to describe sheet dynamics. Two possible
measures of sheet dynamics are the velocity of sheet edges and the out-of-plane fluctuations
of sheets. To our knowledge, neither of these approaches have yet been implemented for
perinuclear ER sheets in vivo. Theoretical predictions have been made for the out-of-plane
fluctuations of membrane sheets. The MSD of these undulations is predicted to increase as
τ2/3 for free membranes and more slowly, as ln(τ), for membranes under tension [246].
Experimentally, some studies have considered the dynamics of lamellar ER at the cell
periphery. Joensuu et al. [188] discovered that the location and dynamics of peripheral
ER sheets are dependent on actin filament arrays and foci. ER sheets were found to
dynamically rearrange in response to the movement of actin structures. The disappearance
of actin led to ER sheets filling in the space left behind and the formation of new actin
structures caused the opening of a fenestration in an ER sheet. The dynamics of sheet
edges were also studied. Sheets fluctuated in a small area and showed no preference for
direction in untreated cells. Treatment with the actin polymerisation inhibitor, latrunculin
A, increased the lateral movement of sheets as well as the proportion of sheets undergoing
fission, fusion, or transformations into tubules.
The studies detailed in this section show that the fluctuations of established structures
within the ER are complex, varied and influenced by many subcellular organelles and
processes. The interplay between ER dynamics and the dynamics of other subcellular
organelles and structures is only just beginning to be understood and fruitful research in
this area is expected in the near future.
3.3. Dynamics of Membrane and Lumenal Components
The processes carried out by the ER involve an abundance of transmembrane and
lumenal proteins, many of which move in order to seek out interacting partners. The
dynamics of these proteins, as well as the lipids forming the ER membrane may affect the
overall dynamics of the organelle.
Fluorescence techniques such as single-particle tracking (SPT), fluorescence recovery
after photobleaching (FRAP), and fluorescence correlation spectroscopy (FCS, reviewed
in [247]) have been used to quantify lipid and protein motion. Computer simulations
have also been used to study the dynamics of objects embedded in membranes, as the
fluorescent probes used to track subcellular objects are thought to hinder dynamics. High
concentrations of the fluorescent dye Rhodamine are proposed to cause hydrodynamic
drag, decreasing the diffusion coefficient of the objects of interest by up to 20% [248].
Several membrane properties are known to influence the dynamics of transmembrane
and lumenal components: lipid rafts, protein concentration, protein folding status, cy-
toskeletal interactions, and membrane tension. Lipid rafts are domains of clustered lipids
and proteins that move within the bilayer [249]. Diffusion was found to be slower by a fac-
tor of two within lipid rafts [250], and lipids and proteins can become transiently confined
to these rafts, in which a hindered, sub-diffusive motion was observed [251]. Higher con-
centrations of proteins within the lipid bilayer are also known to slow lateral diffusion [252],
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with simulations concluding that lateral diffusion in highly crowded membranes was a
factor of 5-10 slower than in dilute membranes [253]. FCS experiments also showed that
the folding status of transmembrane proteins affects their motion within the ER membrane.
Several proteins were analysed, all of which were found to move sub-diffusively [254].
The anomalous exponent of unfolded VSVG was found to be lower than that of its folded
form. This highlights the more obstructed dynamics of unfolded proteins. The binding
of calnexin, a transmembrane chaperone protein, to unfolded VSVG caused an increase
in the anomalous exponent such that the motion was indistinguishable from the folded
form. This result indicates that calnexin may prevent the formation of harmful immobile
structures of unfolded proteins.
Collisions between the cytoplasmic domains of transmembrane proteins and cytoskele-
tal filaments are also known to slow lateral movement within lipid bilayers [255], as has
been shown for transferrin receptor (TfR) at the plasma membrane. Under normal condi-
tions, slow, confined motion of TfR was observed; when actin was depolymerised with
latrunculin, free diffusion was observed [256]. Photoactivation experiments in tobacco leaf
epidermal cells however found that transmembrane proteins in the ER exhibited slower,
diffusive dynamics when treated with latrunculin B in comparison to the active dynamics
observed in untreated cells [257]. This is most likely due to the myosin-driven reorganisa-
tion of the ER in plant cells (Section 3.1.4). Another example of transmembrane protein
dynamics being altered by cytoskeletal interactions is the motion of ER exit sites. ERES
move sub-diffusively along ER tubules in a microtubule-dependent manner [61,180]. Lower
anomalous exponents and smaller diffusion coefficients were measured when cells were
treated with nocodazole, indicating that microtubular activity promotes ERES dynamics.
In simulations, applying tension to the membrane, as would happen with motor activity,
increased the lateral diffusion coefficients of lipids in the bilayer, without altering their
anomalous exponents [258]. The anomalous exponents were sub-diffusive, with a value of
~0.75 observed for all membrane tensions. The dynamics were also found to be dependent
on the direction in computer simulations. Deviations in the direction perpendicular to the
bilayer were found to be constrained, whereas lateral motion in the plane of the bilayer
was not [259].
Taken together, these results show that the dynamics of membrane lipids and trans-
membrane proteins are complex and depend on the composition and state of the lipid
bilayer, and upon interactions with the cytoskeleton.
The dynamics of substrates within the lumen of the ER have also been measured
experimentally. Translational diffusion of proteins within the lumen of the ER was first
experimentally explored using green fluorescent protein (GFP) in 1999 [260]. The motion
of GFP in the ER lumen was found to be significantly slower than in the cytoplasm and
in mitochondria. The dynamics of calreticulin, a lumenal chaperone protein, were found
to depend on the folding environment of the ER [261]. In quiescent cells, calreticulin
was found to readily sample the whole ER, whereas slower diffusion coefficients were
observed in actively metabolising cells. Single-particle tracking experiments revealed
that both calreticulin and ER-targeted lumenal HaloTag proteins moved with slower
velocities at ER junctions than in tubules [181]. The faster population was diminished upon
ATP depletion, indicating that the ATP-dependent motor protein-mediated dynamics of
the ER may contribute to the dynamics of lumenal components. This velocity difference
between tubules and junctions was not observed for the transmembrane chaperone calnexin.
Treatment of Cos-7 cells with latrunculin B led to faster lumenal protein dynamics, as
did removing N-glycans from the proteins of interest [262]. This study, along with the
experiments using TfR described above [256], indicate that actin may play a major role in
governing the motion of proteins and lipids in the lumen and membrane of the ER.
A causal connection between the motion of the ER and the motion of lumenal or
membrane-bound components is yet to be made. However, several hypotheses have been
proposed. Georgiades et al. proposed that the oscillations of ER tubules promote the
mixing of reactants within the lumen, speeding up the biosynthetic processes performed
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in the ER [25]. Similarly, Stadler et al. suggest that the motion of ERES is caused by ER
network fluctuations, which are strongly microtubule-dependent [180]. Holcman et al. take
a different approach and propose that ATP-dependent peristalsis-like contractions in ER
tubule diameters generate active transport of lumenal components [181]. It is clear that
the movement of the ER and the dynamics of ER-resident components are linked, and it is
thought that the motion of the ER increases the efficiency of cellular processes carried out
in the organelle, although this has not yet been confirmed.
3.4. Computational Analysis of ER Dynamics
Analysing the dynamics of the ER in vivo is challenging due to its complex morphol-
ogy and rapid dynamics as well as the phototoxicity of fluorescence microscopy experi-
ments. Mathematical modelling of the network is an opportunity to gain further insights
into this complex system from a different viewpoint. ER tubules can be regarded as semi-
flexible polymers, with junctions represented by cross-links. Recently, many groups have
modelled the dynamics of such cross-linked networks of semi-flexible polymers [263–266],
including those influenced by active forces such as molecular motors [267–270]. Such
models may provide insights into ER network dynamics by simplifying the system and
only considering interactions with microtubules. A recent study modelling the motion of
a particle surrounded by a network of semi-flexible polymers may provide insights into
the functional reason for active rearrangements of the ER. Gong et al. [270] found that
diffusion of a particle embedded in a network of semi-flexible polymers was enhanced by
the presence of active motors. Diffusion of particles in a network with active motors was
super-diffusive, whereas, without active motors, sub-diffusion was observed. A possible
explanation given for this enhanced motion was the greater number of collisions between
the particle and the network in the presence of active motors. This result may relate to
the dynamics of particles in the lumen of the ER. Fluctuations in the tubules and sheets of
the network may induce faster dynamics of the particles within the lumen due to more
frequent collisions with the lumenal face of the lipid bilayer.
It has also been shown that certain aspects of plant ER morphology and dynamics
can be replicated by considering the ER as a minimal network [271–273], where points are
connected using the minimum length of tubules possible. This model accurately recreates
aspects of ER morphology and dynamics. The structure of tubular regions of the network
is accurately recreated, as are the dynamics of ring closure. This approach, however, is
as yet unable to relate the rapid rearrangement dynamics of the network found using the
model to those observed experimentally [273].
The motion of lumenal particles has also recently been simulated. A model describing
the dynamics of particles within the lumen of the ER searching for reaction partners con-
cluded that the morphological properties of the network are the most influential factors in
determining the exploration times of molecules [274]. Future improvements in imaging
data, as well as in the models used to represent the ER network, will result in improve-
ments in both the conclusions of computational models and in workflows for analysing
experimental data.
Recently, several groups have released open-source software designed to extract
dynamic variables from videos of the ER in live cells [24,27]. Such methods to quantify the
morphology and dynamics of the ER network are essential to advance our understanding
of this organelle. Analysing the changes in dynamics and morphology under various
cellular conditions will shed light on the underlying reason for ER dynamics and how
altered dynamics may lead to clinical pathologies.
4. Morphology, Dynamics & Disease
It is unsurprising that an organelle such as the ER, with its critical and diverse func-
tions, would be involved in many diseases. Dysregulation of the morphology and distri-
bution of the functional subdomains of the ER (as described in Section 2.2) is therefore
likely to affect their function and may result in disease states, particularly in neurons [32].
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In fact, many ER morphology-regulating proteins are known to be mutated in human
diseases [227]. Miscommunication between the ER and mitochondria has also been iden-
tified as a contributor to many diseases, either via dysregulation of calcium ion transfer,
insulin signalling, or mitochondrial division. Interactions between the ER and endo-
somes/lysosomes are similarly vital for normal cellular function, with particular problems
being seen in neurons when proteins involved in these interactions are mutated [195,227].
Additionally, many organisms that give rise to pathogenic infections rely on ER machinery
for their replication or entry into the cell. The best-characterised proteins involved in both
diseases and in ER maintenance are summarised in Table 1. Another major factor in many
diseases, particularly cardiovascular diseases, is ER stress. MCSs are affected by many
other types of stress [85,275], and so this is likely to prove an important factor in disease.
Further work is needed to fully explore the interplay between ER morphology and ER
stress. Links between excessive ER stress, UPR activation, and the onset of diseases were
recently reviewed [276–278], but are not addressed here.
Table 1. Diseases related to ER morphology and dynamics. The proteins mutated in the disease or related to the replication
of the pathogen are listed, alongside their normal functions in the ER and how their function is affected/hijacked in
the disease.
Disease Protein Implicated Protein Role in Healthy ER Function Affected in Disease
Hereditary Spastic Paraplegias
Spastin [279] ER tubule regulation [17],ER-endosome MCS [177] Endosomal fission fails at MCS [177]
Protrudin [280]
ER membrane curvature and
tubule fission [281], ER-endosome
MCS [204], ER MCS-dependent
endosome maturation [125]
ER morphology and function
dysregulated [225,281]
Seipin [282] ER-lipid droplet MCS [283] Axon regeneration impaired [284]
Atlastin-1 [285] ER membrane fusion [5] ER morphology dysregulated [17]
REEP1 [286] ER membrane curvature [2],ER-mitochondria MCS [106]
ER-mitochondria interactions
disrupted [106]
REEP2 [287] ER membrane curvatureregulation [2] ER morphology disrupted [288]
KIF5A [195] ER dynamics via kinesin-1 [195] Impaired axonal transport [195]
Amyotrophic Lateral Sclerosis




VAPB and oxysterol binding protein
(OSBP) perturbed [298]




Sigma-1 Receptor [300] ER-mitochondria MCS [301], ERCa2+ homeostasis [301]
Disrupts ER-mitochondria
MCS [302]







Mitofusin 2 [306] ER-mitochondria MCS [105] Reduction in ER-mitochondriaMCS [307]
KIF5A [195] ER dynamics via kinesin-1 [195] Impaired axonal transport [195]
Diabetes
Mitofusin 2 [308] ER-mitochondria MCS [105] Insulin signaling impaired [309]
VDAC-1/grp75/IP3R-1 [310]
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Miro1 [318] ER-mitochondria MCS [319] Altered ER-mitochondria Ca
2+
transfer [320]
Parkin [321] ER-mitochondria MCS [322] Altered ER-mitochondria Ca
2+
transfer [322]
DJ-1 [323] ER-mitochondria MCS [324] Disrupts ER-mitochondria MCSand Ca2+ transfer [324]
α-synuclein [325] ER-mitochondria MCS [326] Fewer ER-mitochondriaMCS [326]
PINK1 [327] ER-mitochondria MCS [328] Altered ER-mitochondria Ca
2+
transfer [328]
LRRK2 [329] ER-mitochondria MCS [330] Disrupts ER-mitochondriaMCS [330]
Alzheimer’s Disease
Presenilins [331] ER Ca2+ homeostasis [332] Ca
2+ homeostasis dysregulated
[333–335]
Reticulon 3 [336] ER morphology regulation,Golgi to ER trafficking [337]
Amyloid plaque formation
altered [336,338], cognitive
dysfunction due to Rtn3
aggregates in AD brains [339]
Encephalopathy Dynamin-related protein 1[340] ER-mitochondria MCS [73]
Defective mitochondrial
fission [340]
Retinal Dystrophy ACBD5 [341] ER-peroxisome MCS [136,342] Unknown
Warburg Micro Syndrome Rab18 [29]
ER-lipid droplet MCS [343],








Ca2+ dynamics implicated Various
Hereditary Sensory and
Autonomic Neuropathy Atlastin-3 [346,347] ER tubule fusion [348]
Aberrant bundling of ER
tubules [349]
Spinocerebellar Ataxia Type 2 Ataxin-2 [350] ER morphology anddynamics [28]
ER morphology collapse, ER
dynamics impaired [28]
Legionnaires’ Disease




Reticulon 4 [352] ER membrane curvature [2]
Connects ER to pathogen by
binding Ceg9 [352] to promote
bacterial replication [351]
Chlamydia
VAPA & VAPB [353] MCS between ER and manyorganelles (reviewed [84])
Chlamydia protein IncV binds
VAP to form ER-bacterial
inclusion MCS [353]
CERT [354] ER-Golgi ceramide transfer[117]
Chlamydia protein IncD binds






STIM1 localises to ER-bacterial
inclusion MCS [355]
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Table 1. Cont.
Disease Protein Implicated Protein Role in Healthy ER Function Affected in Disease
Brome mosaic virus Reticulons [356] ER membrane curvature [2]
Reticulons bind viral protein 1a
to promote viral
replication [356]
Enterovirus 71 Reticulon 3 [357] ER morphology regulation,Golgi to ER trafficking [337]
Enterovirus protein 2C binds
Rtn3 to promote viral
replication [357]
Flaviviruses




ER morphology-regulating proteins are implicated in many diseases, including multi-
ple neurodegenerative disorders (see [227] for an excellent, thorough review). Atlastins, a
family of proteins that mediate the fusion of ER tubules to the network [4,348], are known
to be mutated in hereditary spastic paraplegia (HSP) [285] and hereditary sensory and au-
tonomic neuropathy (HSAN) [346,347]. REEPs and protrudin, which are known to stabilise
regions of high membrane curvature in the ER [2,281], are also mutated in some forms of
HSP [280,286], suggesting that abnormal ER morphology plays a role in the disease.
ER-late endosome/lyosome MCSs are frequently seen in neurons [70] and are clearly
vitally important given that they are commonly affected by disease-causing mutations
(Table 1; [227]). Protrudin mutations may affect ER distribution in axons, due to its interac-
tions with kinesin-1, and its role in generating motile ER tubule-late endosome MCSs [205].
This function is vital for efficient neurite extension [129,195,204,227]. Mutations in KIF5A
could conceivably affect this pathway. The disruption of ER–endosomal interactions also
affects endosomal sorting and leads to lysosomal defects (Section 2.2.6 and 3.1.2), and this
is frequently linked to diseases such as HSP and ALS (Table 1), where it can be caused by
mutations in spastin, strumpelin, REEP1 [177], and VAPB, as described elsewhere in this
special issue [291].
Mutations in proteins regulating ER morphology and dynamics have also been as-
sociated with amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Warburg Micro
syndrome and spinocerebellar ataxia type 2. Reticulon 3 and 4 are mutated in Alzheimer’s
disease [336] and ALS [299], respectively. Reticulons regulate ER membrane curvature [2]
and their mutation in ALS changes the distribution of chaperone proteins within the
ER [299] and therefore is likely to negatively affect ER function. Recently, Mookherjee
et al. discovered that protein aggregation in the cytoplasm, a common hallmark of neu-
rodegenerative diseases, affects both ER morphology and dynamics [359]. Reticulon 4 was
found to bind to the cytoplasmic aggregates, which may be the cause of the abnormal ER
structure observed. Fewer three-way junctions, slower lumenal dynamics, and impaired
tubule fusion efficiency were observed in cells with protein aggregates. Therefore not only
do morphology-regulating proteins play a role in the onset of the disease, but they may
also influence cellular processes once the disease has progressed.
Warburg Micro syndrome, a rare disorder that results in neurodevelopmental defects,
can be caused by mutations in Rab18 [29]. Rab18 is involved in several ER-related processes
including the regulation of ER-lipid droplet MCS involving the NRZ complex and SNARE
proteins [343,360] (but not under all conditions [8]) and the maintenance of normal ER
morphology [8]. As described in Section 3.1.1, Rab18 has also recently been shown to
promote anterograde ER tubule transport via its interaction with kinectin-1 [198] and in
agreement with this result, the dynamic tubular regions of the network were absent in cells
depleted of Rab18 [8]. A similar relationship between morphology-regulating proteins, ER
dynamics and disease is observed with ataxin-2 in spinocerebellar ataxia type 2 (SCA2).
Mutations in ataxin-2 are known to cause SCA2 [350]. Depletion of ataxin-2 increased the
proportion of sheets in the ER network as well as hindering both tubular and lumenal
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dynamics [28]. Unidirectional, long-distance translocation of tubules was diminished and
FRAP experiments showed that the transport of lumenal components was much slower in
the absence of ataxin-2 [28]. Mutations in Rab18 and ataxin-2, proteins known to play a role
in extending ER tubules, both cause defects in tubular morphology as well as dynamics.
Alongside membrane-shaping proteins and proteins involved in ER-late endosome/
lysosome MCSs, another likely cause for diseases is the miscommunication between the
ER and mitochondria. ER–mitochondria MCS are important sites of Ca2+ ion transfer [275].
Impaired calcium homeostasis was first proposed as a possible cause for neurodegenerative
diseases by Khachaturian in 1994 [361]. Since then, mutations in many proteins regulating
ER–mitochondria MCS have been implicated in human diseases. Mutations have been
found in six proteins that are either recruited to, or involved in forming ER–mitochondrial
MCSs in Parkinson’s disease: Miro1 [318], Parkin [321], DJ-1 [323], α-synuclein [325],
PINK1 [327], and LRRK2 [329]. These mutations were all found to alter calcium ion
transfer between the organelles, disrupt ER–mitochondrial MCS, or both (see Table 1). It is
important to note that Miro1 also recruits kinesin-1 to mitochondria, and KIF5A mutations
have been shown to affect mitochondrial motility [362]. In Alzheimer’s disease, mutations
in presenilins also perturb calcium ion homeostasis [335]. In this case, however, it is the
operation of ryanodine receptors (RyR) and inositol 1,4,5-triphosphate receptors (IP3R) that
are dysregulated, rather than the MCSs [333,334,363]. Charcot Marie Tooth (CMT) disease
has also been linked to mutations in ER–mitochondria MCS-forming proteins [303,306],
although no link has been found between CMT and calcium dynamics.
The dysregulation of membrane contact sites between the ER and mitochondria has
also been implicated in other non-neurodegenerative diseases. Impaired insulin signalling,
a hallmark of diabetes, is observed in cells with mutations in mitofusin 2 [308,309] and
the VDAC-1/grp75/IP3R-1 Ca2+ transfer complex [310], both of which tether the ER and
mitochondria at MCSs. Additionally, many proteins at the ER–mitochondria interface have
been implicated in various cancers (reviewed in [345]). Abnormal mitochondrial fission
at ER–mitochondrial MCSs due to mutations in dynamin-related protein 1 also lead to
encephalopathy [340]. Additionally, ER–mitochondrial MCSs have been linked to ALS via
mutations in the sigma-1 receptor [300], which is involved in Ca2+ homeostasis at MCSs.
These MCSs were disrupted in mutant cells [302]. ALS mutations have also been linked to
altered Ca2+ dynamics at ER–mitochondrial MCSs. The ALS mutant form of VAPB leads to
an altered MCS with the outer mitochondrial membrane protein PTPIP51, perturbing Ca2+
uptake at these MCSs [296]. Many other ALS mutations affect ER–mitochondrial contacts,
such as those in VAPB (see reviews by Chen et al. and Borgese et al. in this issue [275,291]).
Intracellular calcium homeostasis also involves MCSs between the ER and the plasma
membrane. Upon depletion of ER calcium stores, extracellular Ca2+ is transferred across
the plasma membrane into the ER at MCS via SOCE. The ER-resident protein STIM1
and the plasma membrane-resident protein Orai1 form a complex, facilitating SOCE
(see Section 2.2.4). Mutations in either, or both of these proteins are known to cause
tubular aggregate myopathy (TAM) and the related condition Stormorken syndrome via
dysregulation of calcium homeostasis [311–315]. Since STIM1 binding to EB proteins
generates TACs, it will be interesting to determine the effects these mutations have on
TAC-based ER tubule extension.
Pathogenic infections are also linked to ER-related proteins. Pathogens hijack the ER
in the host cell to further their replication (reviewed in [364,365]). For several of these
pathogens, proteins have been discovered that bind to ER-resident proteins in order to form
MCSs. These sites are crucial for pathogen replication. Known ER-interacting pathogens
include Legionella pneumophila [352], Brome mosaic virus (BMV) [356], the non-enveloped
polyomavirus SV40 [206], enterovirus 71 [357], flaviviruses such as the Zika virus [358],
and Chlamydia trachomatis. Reticulons are targeted by Legionella pneumophila via the binding
of Ceg9 [352], BMV via viral protein 1a [356], and enterovirus 71 via enterovirus protein
2C [357]. Pathogen replication is promoted by the binding of reticulons in all three of these
cases [351,356,357]. Legionella pneumophila also interacts with atlastins [352] to promote
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replication [351], as do the flavivirus family members: Dengue virus, Zika virus, and
West Nile virus [358]. Chlamydia trachomatis proteins bind to VAPA, VAPB [353], and
CERT [354] to form membrane contact sites with the ER. Depletion of CERT or the VAP
proteins diminished bacterial replication [354], demonstrating once again that ER-pathogen
MCSs are critical for pathogen replication. Interestingly, ER membrane shaping proteins
have also been found to suppress viral replication. Reticulon 3 was found to bind to non-
structural protein 4B (NS4B) of the hepatitis C virus [366]. The self-oligomerisation of NS4B
facilitates viral replication [367]. However, when reticulon 3 is bound, self-oligomerisation
of NS4B is prevented and therefore viral replication is suppressed [366]. SV40 enters the
cytoplasm by penetrating through the ER membrane using the ERAD machinery [368],
most likely in an expanded perinuclear ERQC (Section 2.2.1), and this has been suggested
to involve kinesin-1 function via binding to B14, an ER-localised DNA-J domain-containing
membrane protein [206].
In summary, mutations in single proteins can have catastrophic effects on ER mor-
phology, dynamics, and MCSs, leading to clinical pathologies. In many cases, morphology,
dynamics, and MCSs are tightly linked, with mutations affecting one of these three at-
tributes often causing knock-on effects for the others. Recent research into disease-causing
mutations is beginning to consider ER morphology and dynamics as related topics, as op-
posed to viewing them independently. Future work in this area is likely to provide insights
into the relationship between morphology and dynamics as well as how ER dynamics are
involved in diseases that are known to alter morphology.
5. Discussion
Many proteins that are responsible for regulating ER morphology have been identified
and the links between morphology and function are now becoming clear. We are only just
beginning to quantify ER dynamics and to understand what effect the dynamics may have
on the processes performed by the organelle. Mutations in morphology-regulating proteins
have been found to cause many human diseases (Table 1) and in many cases, the structure
of the ER was abnormal, indicating that the morphology, dynamics, and function of the ER
are intrinsically linked. ER dynamics are also clearly vitally important in establishing and
maintaining the organisation of the ER and its many MCSs. Again, the proteins involved
are commonly mutated in disease. A key challenge for the future is to define the roles
played by these dynamics, and tease apart the contribution of different kinds of motility.
This will need faster frame rate imaging that has commonly been used, since highly motile
ER tubules and potentially interacting organelles move at speeds of up to 5 µm/s, and
cannot be reliably detected when imaging at one frame every 1.5–5 s, as have commonly
been used (e.g., [22,38,75,176,219]). It is also important to note that the go-to cell line for
studying ER dynamics, the Cos-7 cell, has a much less dynamic ER than other cell lines [20].
The advent of super-resolution microscopy of fixed and live cells will continue to provide a
wealth of new understanding of ER structure and dynamics. We expect that with the recent
publication of several methods to analyse and quantify ER dynamics, more links between
dysregulated ER dynamics and disease will be discovered. Hopefully, these discoveries
will result in further understanding of the functional basis for ER movement. The future of
ER dynamics research looks bright!
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